Thermobalancing therapy as a self-management tool

• Autorzy: Allen S.
• Języki publikacji: EN

Abstrakty

EN

People live with one or more chronic diseases, medical and surgical treatments of which may affect their quality of life negatively. Thermobalancing therapy (TT) and Dr Allen’s therapeutic Devices (DATD) for the first time uses own body energy to treat chronic internal diseases. This invention received a US patent. Here we observe condition of people with benign prostatic hyperplasia (BPH), kidney stone disease and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) before and after use of TT and DATD. 10 years of empirical evidence has been studied in people with kidney disease, CP/CPPS and BPH. 2 clinical controlled trials on TT with DATD were conducted. The dynamics of clinical characteristics and parameters, such as pain, urinary symptoms and ultrasound prostate volume (PV), were compared with the no-treatment control groups. 124 men with BPH and 45 men with CP/CPPS used DATD for 6-month period, as mono-therapy, in clinical trials. The outcomes confirmed that TT with DATD reduced pain and PV in men with CP/CPPS and PV and urinary symptoms in men with BPH, while there were no positive changes in the control groups. 4 people with kidney stones, random from the 10-year follow-up, confirmed that after using DATD kidney stones were dissolved without side effects and complications. DATD is a class-1 medical device, which do not need an involvement of notified body, and it is easy use this device. Therefore, people with kidney stones, CP/CPPS and BPH should use DATD, as a tool for self-management in the first place.

• Wydawca: -
• Czasopismo: World News of Natural Sciences
• Rocznik: 2019
• Tom: 23
• Opis fizyczny: p.84-93,fig.,ref.

Twórcy

autor

Allen S.

• Fine Treatment, 29 Rewley Road, Oxford, OX1 2RA, U.K.

Bibliografia

• [1] Grover A, Joshi A. An Overview of Chronic Disease Models: A Systematic Literature Review. Global Journal of Health Science 2015; 7(2): 210-227. doi:10.5539/gjhs.v7n2p210
• [2] Desmedt M, Vertriest S, Hellings J, Bergs J, Dessers E, et al. Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review. Value Health 2016 Sep - Oct; 19(6): 892-902. doi:10.1016/j.jval.2016.05.001
• [3] Jonkman NH, Groenwold RHH, Trappenburg JCA, Hoes AW, Schuurmans MJ. Complex self-management interventions in chronic disease unravelled: a review of lessons learned from an individual patient data meta-analysis. J Clin Epidemiol. 2017 Mar; 83: 48-56. doi:10.1016/j.jclinepi.2017.01.004
• [4] Richardson J, Loyola-Sanchez A, Sinclair S, Harris J, Letts L, et al. Self-management interventions for chronic disease: a systematic scoping review. Clin Rehabil. 2014 Nov; 28(11): 1067-77. doi:10.1177/0269215514532478
• [5] Bos-Touwen ID, Trappenburg JC, van der Wulp I, Schuurmans MJ, de Wit NJ. Patient factors that influence clinicians' decision making in self-management support: A clinical vignette study. PLoS One 2017; 12(2): e0171251
• [6] Allen S, Adjani, A. Therapeutic Device and Method, United States Patent and Trademark Office. U.S. Patent 9,408,744 B2, 9 August 2016. Available online: https://www.google.com/patents/US9408744 (accessed on 1 June 2018).
• [7] Allen, S. The Origin of Chronic Diseases Can Be in Capillary Pathology: An Evidence from Clinical Trials on Thermobalancing Treatment of Prostate Reveals. Achievements in the Life Sciences Volume 10, Issue 2, December 2016, Pages 197-202, doi:10.1016/j.als.2016.11.005
• [8] Allen, S. The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy. Diseases 2017, 5(4), 25; doi:10.3390/diseases5040025
• [9] Allen S. The Cause, Aetiology and Physiopathology of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) and its Effective Treatment with Thermobalancing Therapy. Med Sur Urol. 2018, 7: 207 DOI: 10.4172/2168-9857.1000207
• [10] Allen S, Aghajanyan IG. Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology. Aging Male, 2016, 1-5, http://dx.doi.org/10.1080/13685538.2016.1247151
• [11] Allen S, Thermobalancing Therapy Should be the First-Line Treatment for Kidney Stones and Benign Prostatic Hyperplasia, Discussions at the Medical Conferences. ARC Journal of Urology 2017; 3(1):1-8 doi: dx.doi.org/10.20431/2456-060X.0203001
• [12] Walz J, Perrotte P, Hutterer G, et al. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int. 2007; 100: 1307–1311 https://doi.org/10.1111/j.1464-410X.2007.07250.x
• [13] Wang W, Guo Y, Zhang D, Tian Y, Zhang X. The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys. Scientific Reports 2015; 5:13546. doi:10.1038/srep13546
• [14] Scales CD, Tasian GE, Schwaderer AL, Goldfarb DS, Star RA, Kirkali Z. Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. Clinical Journal of the American Society of Nephrology: CJASN. 2016; 11(7): 1305-1312. doi:10.2215/CJN.13251215
• [15] Anstey Watkins J, Goudge J, Gómez-Olivé FX, Huxley C, Dodd K, Griffiths F. mHealth text and voice communication for monitoring people with chronic diseases in low-resource settings: a realist review. BMJ Global Health 2018; 3(2): e000543. doi:10.1136/bmjgh-2017-000543
• [16] Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. 2014 Apr 29; (4):CD007768. doi:10.1002/14651858.CD007768.pub3
• [17] Aghajanyan IG, Allen S. Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis. Diseases 2016, 4, 18. doi:10.3390/diseases4020018
• [18] Allen S. Innovative Thermobalancing therapy can help millions of men with enlarged prostate gland to improve the quality of life and well-being throughout the world. World Scientific News 105 (2018) 51-61
• [19] Allen S, Aghajanyan IG. Effect of thermobalancing therapy on chronic prostatitis and chronic pelvic pain syndrome. Journal of Clinical Urology, 2016, Sept 20, 1-8. doi: 10.1177/2051415816671036
• [20] Allen S, Aghajanyan IG. New independent thermobalancing treatment with therapeutic device for internal diseases: chronic prostatitis and chronic pelvic pain syndrome. Nephrourol Mon. 2017, 44694, DOI: 10.5812/numonthly.44694
• [21] Allen S, Aghajanyan IG. Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device, Urol J. 2015, 14; 12(5): 2371-2376
• [22] Allen S, Aghajanyan IG. Thermobalancing conservative treatment for moderate – to - low - degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement. Cogent Medicine, 2016, 3(1), 1195067 https://doi.org/10.1080/2331205X.2016.1195067
• [23] Allen S. Dr Allen’s Therapeutic Devices Should be Implemented in the Healthcare System for the Treatment of Chronic Noncancerous Prostate and Kidney Diseases Saving People’s Well-Being and Money. Ann Mil Health Sci Res. 2018; 16(2):e81033. doi: 10.5812/amh.81033